Passage Bio, Inc. filed a Form 8-K on November 6, 2026, reporting the results of a Special Meeting of Stockholders held on November 5, 2026, at which stockholders approved equity compensation plans and merger-related proposals connected to the company's planned combination with Remix Therapeutics, …
EVERTEC, Inc. filed a Form 8-K on November 6, 2026, disclosing that its subsidiary Evertec Group, LLC entered into a seventh amendment to its credit agreement on November 5, 2026, refinancing existing debt facilities and expanding its revolving credit capacity.
K&F Growth Acquisition Corp. II filed a Form 8-K on November 6, 2026, reporting the results of an extraordinary general meeting held November 4, 2026, at which shareholders approved an extension of the initial business combination deadline and ratified the company's independent auditor.
Onconetix, Inc. filed a current report on Form 8-K on November 6, 2026, disclosing that the company and its counterparties executed the First Amendment to the Share Exchange Agreement with Realbotix on November 4, 2026, modifying several key terms of the transaction originally signed …
Sylvamo Corporation filed a Form 8-K on November 6, 2026, disclosing that it has entered into a put option agreement with Midas Atlantic Partners, in partnership with The Najafi Companies, for a binding offer to acquire the company's Europe business.
Coca-Cola Europacific Partners plc filed a Form 6-K on November 6, 2026, announcing the appointment of Sean Summers as an Independent Non-executive Director, effective December 1, 2026.
Starry Sea Acquisition Corp filed a current report on November 6, 2026, disclosing that on November 3, 2026, it deposited $60,000 into its trust account to extend its business combination deadline by one month, from November 7, 2026 to December 7, 2026.
Onconetix, Inc. filed a current report on Form 8-K on November 6, 2026, disclosing that on November 4, 2026, it entered into the First Amendment to its Share Exchange Agreement with Realbotix Corp., Simulacra Corporation, and Realbotix, LLC.
X Financial filed a Form 6-K on November 6, 2026, disclosing that its board of directors received a preliminary non-binding proposal from Mangrove Coast Investment Limited to acquire all outstanding ordinary shares not already owned by Mangrove at US$1.005 per ordinary share, or US$6.03 …
Inflection Point Acquisition Corp. VII filed a Form 425 on November 6, 2026, disclosing that the SEC declared effective the Form S-4 registration statement for its proposed business combination with Elroy Air, Inc., with a shareholder vote scheduled for November 25, 2026.